Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate.
D000293:Adolescent; D000328:Adult; D005260:Female; D006560:Herpes Labialis / Q000188:drug therapy*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000188:drug therapy*; D011458:Prostaglandins E / Q000037:antagonists & inhibitors
D011458:Prostaglandins E; D016651:Lithium Carbonate; D008094:Lithium